Form 4 for ALAB Astera Labs, Inc.
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-07 · accession 0001736297-25-000104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-08-11 | 2025-08-07 | ALAB | Mohan Jitendra | CEO, Dir | S - Sale | $170.33 | -152.5K | 450.0K | -25% | -$25.98M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-07 | S | D | 25,423 | $170.33 | 4,280,002 | I By Living Trust | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (F3) (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. (F4) These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2025-08-07 | S | D | 25,414 | $170.33 | 699,999 | I By Trust | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (F3) (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. (F5) These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 3 | Common | Common Stock | 2025-08-07 | S | D | 25,420 | $170.33 | 700,000 | I By 2021 Trust 1 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (F3) (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. (F6) These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 4 | Common | Common Stock | 2025-08-07 | S | D | 25,420 | $170.33 | 700,000 | I By 2021 Trust 2 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (F3) (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. (F7) These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 5 | Common | Common Stock | 2025-08-07 | S | D | 25,420 | $170.33 | 450,001 | I By 2022 Trust 1 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (F3) (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. (F8) These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 6 | Common | Common Stock | 2025-08-07 | S | D | 25,420 | $170.33 | 450,001 | I By 2022 Trust 2 | — | — | (F2) The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 3,160 shares sold at prices ranging from $165.3050 to $166.2800, 10,096 shares sold at prices ranging from $166.3000 to $167.2800, 12,689 shares sold at prices ranging from $167.3000 to $168.2900, 20,361 shares sold at prices ranging from $168.3000 to $169.2550, 23,013 shares sold at prices ranging from $169.3000 to $170.2950, 31,359 shares sold at prices ranging from $170.3100 to $171.3000, 28,702 shares sold at prices ranging from $171.3100 to $172.3000, 12,696 shares sold at prices ranging from $172.3300 to $173.2700, 9,562 shares sold at prices ranging from $173.3500 to $174.2200, and 879 shares sold at prices ranging from $174.8600 to $175.0000, inclusive. (F3) (Continued from footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. (F9) These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |